Latest / Stock Movers / Samsung Up, Hyundai Rotem Sinks, Sino Biopharmaceutical Gains
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:16Speaker 2: Now, let's have a look at some of the stocks
- 0:18Speaker 2: on the move today in Asia. I'm Caroline Hipka, and
- 0:20Speaker 2: I'm joined by Bloomberg's markets reporter, Anthony Stevens. Anthony, good morning.
- 0:25Speaker 2: Memory giants are on the up once again. Why and
- 0:30Speaker 2: what's moving?
- 0:31Speaker 3: It's interesting that you have innovation on both sides of
- 0:34Speaker 3: the spectrum. So on the top end of the spectrum,
- 0:36Speaker 3: you have Samsung continuing to expand their manufacturing base and
- 0:40Speaker 3: they're looking to double output of this HBM4 that they've
- 0:44Speaker 3: started to dominate. It's interesting to see Samsung catch Hynix
- 0:47Speaker 3: in terms of production ability. And this comes ahead of
- 0:51Speaker 3: their much-awaited dividend day. So we also have a payout
- 0:54Speaker 3: for shareholders today.
- 0:55Speaker 1: Coming.
- 0:55Speaker 3: That's got the stock up a lot today. It's up 5%. Also,
- 1:00Speaker 3: on the bottom end of the spectrum, or rather the
- 1:02Speaker 3: lower end of the spectrum, you have CXMT saying that
- 1:04Speaker 3: they can catch up to the Koreans in a couple
- 1:07Speaker 3: of years as they improved their manufacturing process. That stock
- 1:10Speaker 3: was up as much as 4%, it's up 2% now.
- 1:13Speaker 3: And it pretty much provides the backbone for China's efforts
- 1:17Speaker 3: to catch up with the Western hardware side. Bear in mind,
- 1:20Speaker 3: just on Friday, we had Huawei release new chips. So
- 1:23Speaker 3: there's a few things coming together for China. And overall,
- 1:26Speaker 3: that's lifting tech sentiment as well between the two ecosystems.
- 1:29Speaker 3: And one of the beneficiaries of that is Taiwan. Taiwan
- 1:32Speaker 3: is near the new record highs. It's, you know, weathered
- 1:36Speaker 3: a lot of storms and it's being led by media
- 1:38Speaker 3: tech today up 6.3%.
- 1:39Speaker 1: Yeah.
- 1:40Speaker 2: Okay. Very interesting. Also, obviously, ahead of the Xi-Trump talks too,
- 1:45Speaker 2: where AI is with such a flashpoint. Meanwhile, the market
- 1:49Speaker 2: is still grappling with the impact from the oil price,
- 1:52Speaker 2: although it's declining and this idea that maybe escalation is
- 1:56Speaker 2: going to be difficult. What are markets thinking about?
- 2:00Speaker 3: Recently, we've seen a declining reaction function to kind of
- 2:03Speaker 3: security worries in the Middle East to oil, and it
- 2:06Speaker 3: seemed to have topped out at 100, right? We saw
- 2:08Speaker 3: oil volatility come up pretty sharply as well. And it
- 2:11Speaker 3: does look like the market has decided on a narrative
- 2:13Speaker 3: of there being too much going on for an escalation
- 2:17Speaker 3: of the war to really happen. And that's hitting both
- 2:20Speaker 3: oil stocks and military stocks across the region. So we
- 2:23Speaker 3: have Hyundai Rotem, which makes artillery, and so does LIG
- 2:28Speaker 3: Defense in Korea as well. Both stocks are down over 2%.
- 2:33Speaker 3: Hyundai Rotem is actually accelerating losses as you guys come in.
- 2:36Speaker 3: That's down three. And then the oil space, Woodside, you know,
- 2:40Speaker 3: is flat-ish, but was down as much as 2%. And
- 2:43Speaker 3: oil itself spent most of the Asian session down two.
- 2:47Speaker 2: And then we have the U.S.-China summit later this week. So,
- 2:51Speaker 2: there's some reporting also around pharma talks. Why are people
- 2:55Speaker 2: excited about that?
- 2:57Speaker 3: This has been a very interesting theme. As the U.S.
- 3:00Speaker 3: pharma gets pressured domestically by Medicaid and Trump's kind of
- 3:05Speaker 3: initiatives to push down the cost of pharma, they want
- 3:08Speaker 3: to go to China to find more innovative molecules at
- 3:11Speaker 3: better margins. And that partnership is driving both healthcare industries.
- 3:16Speaker 3: On top of that, into the weekend, you've had the
- 3:19Speaker 3: China state lead into that effort to by announcing stimulus
- 3:24Speaker 3: plans for the pharmaceutical industry. Bear in mind, last week,
- 3:27Speaker 3: China's state had very punchy plans for the Chinese pharmaceutical industry.
- 3:31Speaker 3: They had a 3.5 trillion yuan revenue target by 2030
- 3:36Speaker 3: for this space. So it was already on fire on Friday,
- 3:39Speaker 3: and it cracks on today. The HS Bio Index is
- 3:43Speaker 3: up 5%, but individual names like CSPC or Insilico or
- 3:49Speaker 3: Sinobio Pharma are up 7% to 9%.
- 3:52Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:56Speaker 1: us throughout the day for the latest roundup of companies
- 3:59Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 4:03Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 4:08Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 4:11Speaker 1: Business app.